Susanne Antonie Schaffert

General Manager Region Europe Oncology at Novartis Venture Fund

Susanne Antonie Schaffert

Susanne Antonie Schaffert

General Manager Region Europe Oncology at Novartis Venture Fund

Overview
Career Highlights

Advanced Accelerator Applications SA
Novartis Oncology, Inc.

RelSci Relationships

859

Number of Boards

4

Birthday

1967

Age

54
Contact Data
Trying to get in touch with Susanne Antonie Schaffert? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
View Relationship Details
RelSci Relationships are individuals Susanne Antonie Schaffert likely has professional access to. A relationship does not necessarily indicate a personal connection.
Marc Ceulemans

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

John Tsai

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Harry Werner Kirsch

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Sidonie Golombowski-Daffner

Chairman & President at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Vasant Narasimhan

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Shannon Klinger

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Bertrand Bodson

Chief Digital Officer at Novartis AG

Relationship likelihood: Strong

Richard Saynor

Chief Executive Officer, Sandoz at Novartis AG

Relationship likelihood: Strong

Jeffrey P. George

Division Head, Alcon at Novartis AG

Relationship likelihood: Strong

Marie-France Tschudin

President of Novartis Pharmaceuticals at Novartis AG

Relationship likelihood: Strong

Reveal deeper insights into your organization's relationships
with RelSci Contact Aggregator.

Empower Your Business Applications with Industry-Leading
Relationship Data from the RelSci API.

Get Contact Information on the
World's Most Influential Decision Makers.

Discover the Power of Your Network with
RelSci Premium Products.
In The News
Nasdaq
January 12, 2021
Novartis, once wary of Chinese M&A, dives into BeiGene's cancer immunotherapy
GlobeNewswire
January 11, 2021
Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene
Thomson Reuters ONE
December 9, 2020
Novartis Kisqali(R) data demonstrate superior benefit across main intrinsic subtypes in metastatic breast cancer
Thomson Reuters ONE
December 9, 2020
Novartis Kisqali(R) demonstrates nearly five years median overall survival in metastatic breast cancer
GlobeNewswire
November 19, 2020
New data at ASH to reinforce breadth of Novartis hematology portfolio across multiple blood cancers and serious hematologic diseases
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Trending People
Patrick Vallance
UK doctors seek review of 12-week gap between vaccine doses - Associated Press
Henry L. "Hank" Aaron
Home run king Aaron dies at 86THE QUOTE - South Florida Sun-Sentinel
Charles E. Schumer
February date set for Trump trialPelosi to send article of impeachment to Senate... - South Florida Sun-Sentinel
Jennifer Rene Psaki
Signing orders, urging more helpBiden offers some aid and asks Congress for bigg... - South Florida Sun-Sentinel
Boris Johnson
Rotting fish, lost business and piles of red tape. The reality of Brexit hits Br... - CNN
Paths to Susanne Antonie Schaffert
Potential Connections via
Relationship Science
You
Susanne Antonie Schaffert
General Manager Region Europe Oncology at Novartis Venture Fund
Career History
Chief Executive Officer
2019 - Current
Novartis Oncology, Inc.

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

General Manager Region Europe Oncology
Current
Novartis Venture Fund

NVF is an active venture capital investor focused on equity investments in Biotechnology/ Biopharma life sciences companies. It engages in seed investments as well as later-stage investments. It typically leads or co-leads an investment and plays an active role on company boards. The investment size is up to USD 30 million per company over its life. The investments are made in North America, Europe, Israel and in Asia/Pacific.

President of Novartis Oncology
Current
Novartis AG

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Other Affiliations

Susanne Antonie Schaffert is affiliated with Novartis Oncology, Inc., Novartis Venture Fund, Novartis AG, Advanced Accelerator Applications SA

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.

Stay informed and up-to-date on your network with RelSci news and business alerting service. Nurture your network and further your business goals with smart intelligence on the people and companies that matter most to you.

Browse in-depth profiles on 12 million influential people and organizations. Find RelSci relationships, employment history, board memberships, donations, awards, and more.

Explore notable alumni from top universities and organizations. Expand your fundraising pool and make warm introductions to potential new business connections.

Harness the power of your relationships with RelSci Pro, the powerful platform for identifying relationship-driven business opportunities and connections that can propel your career forward.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Susanne Antonie Schaffert. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Susanne Antonie Schaffert's profile does not indicate a business or promotional relationship of any kind between RelSci and Susanne Antonie Schaffert.